MassMutual Private Wealth & Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.35K Sell
86
-5
-5% -$522 ﹤0.01% 1463
2026
Q2
$10.7K Buy
91
+1
+1% +$100 ﹤0.01% 1383
2026
Q1
$8.31K Buy
90
+9
+11% +$847 ﹤0.01% 1435
2025
Q4
$6.4K Sell
81
-1
-1% -$72 ﹤0.01% 1576
2025
Q3
$6.01K Buy
82
+1
+1% +$64 ﹤0.01% 1597
2025
Q2
$4.12K Buy
81
+2
+3% +$89 ﹤0.01% 1706
2025
Q1
$3.56K Hold
79
– – ﹤0.01% 1725
2024
Q4
$3.27K Hold
79
– – ﹤0.01% 1685
2024
Q3
$3.08K Buy
79
+5
+7% +$199 ﹤0.01% 1534
2024
Q2
$2.53K Buy
+74
New +$1.94K ﹤0.01% 1556

Other funds holding MIRM

MassMutual Private Wealth & Trust's MIRM Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Mirum Pharmaceuticals (MIRM) stake by 5.5% in Q3 2026, selling an estimated $522 and leaving 86 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

MassMutual Private Wealth & Trust first reported a position in MIRM in Q2 2024 and has held it in 10 quarters since. The position peaked at $10.7K in Q2 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • MassMutual Private Wealth & Trust held 86 shares of Mirum Pharmaceuticals worth $7.35K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 5 Mirum Pharmaceuticals shares in Q3 2026, an estimated $522.
  • Mirum Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1463 holding.
  • MassMutual Private Wealth & Trust first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • MassMutual Private Wealth & Trust's Mirum Pharmaceuticals position peaked at $10.7K in Q2 2026.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.